相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。FHL3 promotes pancreatic cancer invasion and metastasis through preventing the ubiquitination degradation of EMT associated transcription factors
Pengping Li et al.
AGING-US (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Predicted Prognosis of Patients with Pancreatic Cancer by Machine Learning
Seiya Yokoyama et al.
CLINICAL CANCER RESEARCH (2020)
Unsupervised class discovery in pancreatic ductal adenocarcinoma reveals cell-intrinsic mesenchymal features and high concordance between existing classification systems
Frederike Dijk et al.
SCIENTIFIC REPORTS (2020)
High-grade mesenchymal pancreatic ductal adenocarcinoma drives stromal deactivation through CSF-1
Anne Steins et al.
EMBO REPORTS (2020)
A unifying paradigm for transcriptional heterogeneity and squamous features in pancreatic ductal adenocarcinoma
Akimasa Hayashi et al.
NATURE CANCER (2020)
A deep proteome and transcriptome abundance atlas of 29 healthy human tissues
Dongxue Wang et al.
MOLECULAR SYSTEMS BIOLOGY (2019)
Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma
Junya Peng et al.
CELL RESEARCH (2019)
Tumor cell-intrinsic EPHA2 suppresses antitumor immunity by regulating PTGS2 (COX-2)
Nune Markosyan et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Upregulation of Mobility in Pancreatic Cancer Cells by Secreted S100A11 Through Activation of Surrounding Fibroblasts
Yosuke Mitsui et al.
ONCOLOGY RESEARCH (2019)
Proteomic analyses of ECM during pancreatic ductal adenocarcinoma progression reveal different contributions by tumor and stromal cells
Chenxi Tian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Experimental microdissection enables functional harmonisation of pancreatic cancer subtypes
Carlo Maurer et al.
GUT (2019)
Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma
Rocco Sciarrillo et al.
EBIOMEDICINE (2019)
Proteomic analysis of gemcitabine-resistant pancreatic cancer cells reveals that microtubule-associated protein 2 upregulation associates with taxane treatment
Tessa Ya Sung Le Large et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2019)
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
T. Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients
J. Castillo et al.
ANNALS OF ONCOLOGY (2018)
Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition
Eva A. Ebbing et al.
GASTROENTEROLOGY (2017)
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
Daniel Ohlund et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
John P. Neoptolemos et al.
LANCET (2017)
Prognostic value of GLUT-1 expression in pancreatic cancer: results from 538 patients
Gaowa Sharen et al.
ONCOTARGET (2017)
Targeting calcium signaling in cancer therapy
Chaochu Cui et al.
ACTA PHARMACEUTICA SINICA B (2017)
Speeding towards individualized treatment for pancreatic cancer by taking an alternative road
Juan Iovanna et al.
CANCER LETTERS (2017)
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma
Andrew J. Aguirre et al.
CANCER CELL (2017)
2016 update of the PRIDE database and its related tools
Juan Antonio Vizcaino et al.
NUCLEIC ACIDS RESEARCH (2016)
A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets
Dongyu Jia et al.
CANCER LETTERS (2016)
A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2
Shouhui Yang et al.
CANCER RESEARCH (2016)
Mass-spectrometric exploration of proteome structure and function
Ruedi Aebersold et al.
NATURE (2016)
Genomic analyses identify molecular subtypes of pancreatic cancer
Peter Bailey et al.
NATURE (2016)
Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression
Hanane Laklai et al.
NATURE MEDICINE (2016)
Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy
Hong Jiang et al.
NATURE MEDICINE (2016)
Calretinin but not caveolin-1 correlates with tumour histology and survival in malignant mesothelioma
Bibhusal Thapa et al.
PATHOLOGY (2016)
Meta-analysis of transcriptome data identifies a novel 5-gene pancreatic adenocarcinoma classifier
Manoj K. Bhasin et al.
ONCOTARGET (2016)
Glypican-3 and KRT19 are markers associating with metastasis and poor prognosis of pancreatic ductal adenocarcinoma
Hongliang Yao et al.
CANCER BIOMARKERS (2016)
Feasibility of label-free phosphoproteomics and application to base-line signaling of colorectal cancer cell lines
Sander R. Piersma et al.
JOURNAL OF PROTEOMICS (2015)
Carboxylesterase 2 as a Determinant of Response to Irinotecan and Neoadjuvant FOLFIRINOX Therapy in Pancreatic Ductal Adenocarcinoma
Michela Capello et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Myostatin and IGF-I signaling in end-stage human heart failure: a qRT-PCR study
Julia Aliz Baan et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma
Richard A. Moffitt et al.
NATURE GENETICS (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Carboxylesterase 2 as a Determinant of Response to Irinotecan and Neoadjuvant FOLFIRINOX Therapy in Pancreatic Ductal Adenocarcinoma
Michela Capello et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
An assessment of computational methods for estimating purity and clonality using genomic data derived from heterogeneous tumor tissue samples
Vinod Kumar Yadav et al.
BRIEFINGS IN BIOINFORMATICS (2015)
Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
Andrew D. Rhim et al.
CANCER CELL (2014)
TRIM29 as a Novel Biomarker in Pancreatic Adenocarcinoma
Hongli Sun et al.
DISEASE MARKERS (2014)
A Novel Chimeric Antigen Receptor Against Prostate Stem Cell Antigen Mediates Tumor Destruction in a Humanized Mouse Model of Pancreatic Cancer
Daniel Abate-Daga et al.
HUMAN GENE THERAPY (2014)
Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling
Katia Nones et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Genetic and pharmacologic inhibition of EPHA2 promotes apoptosis in NSCLC
Katherine R. Arnato et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Involvement of annexin A8 in the properties of pancreatic cancer
Harumi Hata et al.
MOLECULAR CARCINOGENESIS (2014)
Stars and stripes in pancreatic cancer: role of stellate cells and stroma in cancer progression
Jeremy S. Wilson et al.
FRONTIERS IN PHYSIOLOGY (2014)
The good, the bad and the ugly: a tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms
S. Caponi et al.
ANNALS OF ONCOLOGY (2013)
Calretinin expression in high-grade invasive ductal carcinoma of the breast is associated with basal-like subtype and unfavorable prognosis
Ross J. Taliano et al.
HUMAN PATHOLOGY (2013)
Calretinin is essential for mesothelioma cell growth/survival in vitro: A potential new target for malignant mesothelioma therapy?
Walter Blum et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Overexpression of COL11A1 by Cancer-Associated Fibroblasts: Clinical Relevance of a Stromal Marker in Pancreatic Cancer
Carmen Garcia-Pravia et al.
PLOS ONE (2013)
Whole gel processing procedure for GeLC-MS/MS based proteomics
Sander R. Piersma et al.
PROTEOME SCIENCE (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
Optimized nLC-MS workflow for laser capture microdissected breast cancer tissue
Rene B. H. Braakman et al.
JOURNAL OF PROTEOMICS (2012)
Google Goes Cancer: Improving Outcome Prediction for Cancer Patients by Network-Based Ranking of Marker Genes
Christof Winter et al.
PLOS COMPUTATIONAL BIOLOGY (2012)
A Migration Signature and Plasma Biomarker Panel for Pancreatic Adenocarcinoma
Seetharaman Balasenthil et al.
CANCER PREVENTION RESEARCH (2011)
Critical role of laser microdissection for genetic, epigenetic and proteomic analyses in pancreatic cancer
Niccola Funel et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2011)
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
Eric A. Collisson et al.
NATURE MEDICINE (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Hallmarks of cancer: Interactions with the tumor stroma
Kristian Pietras et al.
EXPERIMENTAL CELL RESEARCH (2010)
Conducting Meta-Analyses in R with the metafor Package
Wolfgang Viechtbauer
JOURNAL OF STATISTICAL SOFTWARE (2010)
Regularized gene selection in cancer microarray meta-analysis
Shuangge Ma et al.
BMC BIOINFORMATICS (2009)
Derlin-1 Is Overexpressed on theTumor Cell Surface and Enables Antibody-Mediated Tumor Targeting Therapy
Yuliang Ran et al.
CLINICAL CANCER RESEARCH (2008)
MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
Juergen Cox et al.
NATURE BIOTECHNOLOGY (2008)
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada clinical trials group
Malcolm J. Moore et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
被撤回的出版物: EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma (Retracted article. See FEB, 2023)
MS Duxbury et al.
ONCOGENE (2004)
分享论文
